Nanobody mimicry of a GPCR recognition site disrupts human C5a-C5aR1 signaling
The human anaphylatoxin C5a is a potent proinflammatory mediator generated during complement activation. C5a acts through the G-protein-coupled receptors C5aR1 and C5aR2, which are implicated in many immune-inflammatory diseases, and blocking C5a-C5aR1 signaling is a promising therapeutic strategy. Here we generate and characterize nanobodies, single-domain antibody fragments, that bind human and mouse C5a with high affinity and fall into two families recognizing non-overlapping epitopes. In cell assays, these nanobodies block C5a-induced receptor activation and downstream signaling. Crystallography shows that the antigen-binding loop of the highest-affinity nanobody mimics a turn in the extracellular amino-terminal region of C5aR1 and C5aR2, so that the nanobody competes with the receptor for the same surface of C5a. An antibody loop and a cell-surface receptor thus converge on analogous solutions for engaging the same ligand. These results inform our understanding of antibody-mediated inhibition of receptor agonists and identify nanobody-based C5a inhibitors as candidates to modulate C5a-driven inflammation.
Authors
- Javier Querol-García (ORCID: https://orcid.org/0009-0006-6667-9556)
- Daniel Ajona (ORCID: https://orcid.org/0000-0001-5517-9165)
- Francisco José Fernández (ORCID: https://orcid.org/0000-0002-5015-1849)
- Serge Muyldermans (ORCID: https://orcid.org/0000-0002-3678-3575)
- Elena Sierra‐Filardi (ORCID: https://orcid.org/0000-0003-4439-2037)
- M. Cristina Vega (ORCID: https://orcid.org/0000-0003-0628-8378)
- Francisco Javier Cañada (ORCID: https://orcid.org/0000-0003-4462-1469)
- Cécile Vincke (ORCID: https://orcid.org/0000-0003-0681-7444)
- Rubén Pı́o (ORCID: https://orcid.org/0000-0002-6831-6111)
- Santiago Rodrı́guez de Córdoba (ORCID: https://orcid.org/0000-0001-6401-1874)
- Sergio Navas-Yuste (ORCID: https://orcid.org/0000-0001-8711-4630)
- Amaia Pereda
- Sergio Camero (ORCID: https://orcid.org/0000-0001-5283-6510)
- Hugo Harasimowicz (ORCID: https://orcid.org/0009-0007-5720-3078)
- Jorge Santos-López
- David Pantoja-Uceda
- Guillermo Tapia-Agudo
- Karla de la Paz-García
Institutions
- Vrije Universiteit Brussel (BE)
- Consejo Superior de Investigaciones Científicas (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Navarre Institute of Health Research (ES)
- Centro de Investigación Biomédica en Red (ES)
- Clinica Universidad de Navarra (ES)
- Instituto de Química Física Blas Cabrera (ES)
- Centro de Investigaciones Biológicas Margarita Salas (ES)
- Centro de Investigación Biomédica en Red de Cáncer (ES)
- VIB-VUB Laboratory Myeloid Cell Immunology (BE)
- Centro de Investigación Médica Aplicada (ES)
- Universidad de Navarra (ES)
Publication Details
- Journal
- Communications Biology
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1038/s42003-026-11320-7
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00